Melanoma Posts on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

Predictive factors of vulvar melanoma outcomes

Posted by on Mar 25, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the factors predictive of survival of patients with vulvar melanoma (VM). Researchers suggested that tumor thickness and mitotic rate (a measure of how fast cancer cells are dividing and growing) are strong predictors of VM outcomes.  Some background VM affects 1.08 to 1.36 per million women every year in...

Read More

Smoking is associated with an increased risk of melanoma lymph node metastasis

Posted by on Mar 20, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the association between smoking and the risk of melanoma lymph node metastasis (LNM; spread to the lymph nodes). Researchers suggested that smoking is associated with an increase in the risk of LNM in melanoma patients. Some background Smoking is a well-known cause of cancer. However, it does not appear to be...

Read More

Vemurafenib is an effective treatment option for BRAF-mutant metastatic melanoma

Posted by on Mar 6, 2017 in Melanoma | 0 comments

In a nutshell This study examined the effectiveness and safety of vemurafenib (Zelboraf) as treatment for BRAF-mutant metastatic melanoma. Researchers concluded that vemurafenib is an effective treatment option for patients with BRAF-mutated melanoma and brain metastasis (BM; spread to the brain). Some background Over 40% of melanoma patients...

Read More

Radiation therapy in melanoma: a review

Posted by on Feb 27, 2017 in Melanoma | 0 comments

In a nutshell This review explored the effects of radiation therapy (RT) to treat melanoma. Researchers suggested that RT is useful in high risk melanoma to prevent recurrence (when the cancer comes back), however without increasing survival. Some background RT has long been used as a treatment for skin cancer. New surgery methods and knowledge of...

Read More

A review of melanoma brain metastasis

Posted by on Feb 24, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the clinical features and outcomes of brain metastases in melanoma (MBM). Researchers reported that to improve outcomes for melanoma patients with brain metastasis, both clinical and pre-clinical efforts are necessary. This will include studying the brain tumor environment and associated treatment toxicities. Some...

Read More

Relapse timing in stage 2 melanoma patients

Posted by on Feb 6, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the timing for relapse of stage 2 melanoma patients. Researchers suggested that patients with stage 2C melanomas are at higher risk of relapse and need a closer follow-up.   Some background Stage 2 melanoma patients can be divided in 3 different groups depending on specific factors such as tumor...

Read More

Guidelines for treatment of ipilimumab-associated hypophysitis in advanced melanoma

Posted by on Nov 21, 2016 in Melanoma | 0 comments

In a nutshell This study developed guidelines for the early detection and treatment of hypophysitis (HP; inflammation of the pituitary gland), a side effect of treatment with ipilimumab. Researchers suggested that these guidelines are necessary to ensure early detection and treatment of this condition to prevent associated mortality. Some background...

Read More